qrr Charles Auer 05/16/2000 11:11 AM RECEIVED O P P T HC1C 2000S E P -6 PH 12: 57 e2G 0 6 2 - 3 To: cc: Subject: Barbara Leczynski/DC/USEPA/US@EPA, Mary Dominiak/DC/USEPA/US@EPA, Frank Kover/DC/USEPA/US@EPA, Ward Penberthy/DC/USEPA/US@EPA, Karen Lannon/DC/USEPA/US@EPA Phaseout of PFOS fyi Forwarded by Charles Auer/DC/USEPA/US on 05/16/2000 11:17 AM Charles Auer 05/16/2000 11:06 AM To: Charles Auer/DC/USEPA/US@EPA, blnetti@iss.it, John.Bucdnl@ec.gc.ca, "IMCEAFAX-3001+5ECHADJICHRISTIDI+2C+20Konstantina-fax+5E3A23+5E3018662968+5E"@oecd.or g, shchung@me.go.kr, theresa.gilgallon@cec.eu.int, addeke@lss.it, karen_florlnl@edf.org, amst@baua.do.shuttle.de, bjorn.hansen@jrc.it, hasa@env.cz, mark.hyman@ea.gov.au, "IMCEAFAX-3001+5EICONOMOU+2C+20Maria+5E3A23+5E3016465123+5E"@oecd.org, geir.jorgensen@sft.telemax.no, Rainer-Kurt.Koch.RK@bayer-ag.de, Thaly.Lakhanisky@iph.fgov.be, ivarl@kemi.se, majka@bware.imp.lodz.pl, matejova.jana@flora.lifeenv.gov.sk, TM-TNG@mhw.go.jp, laurence.musset@environnement.gouv.fr, jrn@mst.dk, esa.nikunen@vyh.fi, caria.piccinni-leopardi@cec.eu.int, raimund.quint@bmu.gv.at, rosenbaum@biac.org, esilber@epi.umaryland.edu, urs.staempfli@buwal.admin.ch, nagata-reiko@miti.go.jp, roger_tregunno@detr.gsi.gov.uk, Hty@mst.dk, ungvary@elender.hu, kees.van.Leeuwen@rivm.nl, vickersc@worksafe.gov.au, jwillis@unep.ch, younesm@who.ch, Dian.TURNHEIM@oecd.org, Naoyuki.YASUDA@oecd.org, Lesley.ONYON@oecd.org, Oscar Hernandez/DC/USEPA/US@EPA cc: robert.visser@oecd.org, robert.donkers@cec.eu.int, Susan Wayland/DC/USEPA/US@EPA, William Sanders/DC/USEPA/US@EPA, Pep Fuller/DC/USEPA/US@EPA, milroy.breck@epamail.epa.gov, ig232001@wp-gate.bmu.de, Priscilla Flattery/DC/USEPA/US@EPA Subject: Phaseout of PFOS I would like to draw your attention to an important development in the US which concerns a persistent, bioaccumulative, and toxic chemical.

AR <AA6 - 06US~ NOTE TO FILE DATE: September 29, 2000 FROM: Karen Lannon SUBJECT: PFOS Substitutes - Carpet Treatment A meeting was held from 1:00 pm to 2:00 pm on September 15, 2000 to discuss PFOS alternatives for carpet treatment.

Larry R.

AfLJlS6 - till RECEIVED 0PPTNCIC 2003JH i 5 AH 10* it) FINAL REPORT PURIFIED 8-2 ALCOHOL: SALMONELLA-ESCHERICHIA COX//MAMMALIANMICROSOME REVERSE MUTATION ASSAY WITH A CONFIRMATORY ASSAY COVANCE STUDY 22900-0-4090ECD STUDY SCHEDULE: Study Initiation Date: Initial Dose Date: Study Termination Date: Final Report Date: 23 October 2001 29 October 2001 10 December 2001 11 February 2002 STUDY DIRECTOR.

- mo ANALYTICAL METHOD VALIDATION FOR THE DETERMINATION OF PERFLUOROOCTANESULFONATE, POTASSIUM SALT (PFOS) IN ARTIFICIAL SOIL WILDLIFE INTERNATIONAL, LTD.

03/13/2003 10:06 oa/ia/oa os:09 UU DEP LEGAL SERUICES -> 915133010205 NO.129 304 026 8738 WV AIR QUALITY At.

Katfcerim E.

Benchmark Doses for Tumors in Sprague Dawley Rats fed N-Ethyl Perfluorooctanesulfonamido Ethanol (N-EtFOSE) David W.

A226r/qo3 SRPT T-6295.8, T-6316.4, T-6868.2, T-7071.1, T-7132.1 DT15-B 3M MEDICAL DEPARTMENT, CORPORATE TOXICOLOGY Title: Comparative Molecular Biology of Perfluorooctanesulfonate (PFOS, T-6295), N-ethyl perfluorooctanesulfonamido ethanol (N-EtFOSE, T-6316), N-Ethyl perfluorooctanesulfonamide (N-EtFOSA, T-6868), Perfluorooctanesulfonamido acetate (FOSAA, T-7071), and/or Perfluorooctanesulfonamide (FOSA, T-7132) of in Rats and Guinea Pigs following Oral dosing.

H18636: Slide Review of pancreas lesions from DuPont APFO Study Date of Review: 28thNovember 2001-11-29 Reviewing Pathologists: Dr E E McConnell and Dr J R Foster Study No: HN-18636 Study Tide: Combined Chronic Toxicity/Oncogenicity Study with Linur-on, C8 and Wyl4,643.

AR226-2198 C h r is E Shoop 08/28/2001 04:10 P M ................_ .. . ...... _ _____ To: cc: Subject Stephen J Gissy/AE/DuPont@ DuPont ' Karl G Kronberg/AE/DuPont@DuPont, Robert I W evodau/SE/DuPont@ DuPont, Debbie J Mulrooney/AE/DuPont@DuPont, Robert F Pinchot/DEV/AE/DuPont@ DuPont Em issions Modeling for Permit Applications Steve, Karl, Bob, and I feel that we will need to have modeling data for the applications we plan to submit or have already submitted for FP, F EP , and PFA.

1 ' AR226-2 273 s GIST meeting notes May 15,2002 Minnies from the C-8 DuPont meeting May 15,2002 The meeting began at approximately 10:20 am.

SEVERN TRENT LABORATORIES ANALYTICAL REPORT JOB NUMBER: 244800 Prepared For: Weston Solutions, Inc. 1400 Weston Way Building 5-2 West Chester, PA 19380-1499 Project: Confidential Decatur - FC Investigation Attention: Jai Kesari Date: 03/13/2006 Signature Name: Richard C.

310 Bos Sfregi Dacotur.

Larry R.